Adicet Bio, Inc.

Filed a patent for "affinity binding entities directed to cd70 and methods of use thereof" on Fri, July 29, 2022

Filed a patent for "affinity binding entities directed to psma and methods of use thereof" on Thu, August 11, 2022

Filed a patent for "affinity binding entities directed to b7h6 and methods of use thereof" on Fri, September 30, 2022

Filed a patent for "methods for expanding gamma delta t-cell populations with multivalent agents and compositions thereof" on Thu, January 12, 2023